Thor Medical ASA (OSL:TRMED)
Norway · Delayed Price · Currency is NOK 4.430
+0.025 (0.57%)
May 15, 2026, 4:25 PM CET
Thor Medical ASA Company Description
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. The company was founded in 2017 and is headquartered in Oslo, Norway.
Thor Medical ASA
| Country | Norway |
| Founded | 2009 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 18 |
| CEO | Jasper Kurth |
Contact Details
Address: Drammensveien 167 Oslo Norway | |
| Phone | 47 97 41 40 00 |
Stock Details
| Ticker Symbol | TRMED |
| Exchange | Oslo Børs |
| Fiscal Year | January - December |
| Reporting Currency | NOK |
| ISIN Number | NO0010597883 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Jasper Kurth | Chief Executive Officer |
| Brede Ellingsæter | Chief Financial Officer and Chief Operating Officer |
| Dr. Sindre Hassfjell | Chief Technology Officer |
| Dr. Alf Bjørseth Ph.D. | Executive Vice President of Business Development and Strategic Advisor |
| Astrid Liland | Executive Vice President of HSEQ |
| Mathias Nilsen Reierth | Head of Communications and Corporate Affairs |
| Therese Kvehaugen | Executive Vice President of Human Resources |